ArticleAmerican journal of public health2018
HIV Preexposure Prophylaxis as a Gateway to Primary Care.
Article in American journal of public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 43 citations in OpenAlex.
- Evaluating mental health integration in PrEP programs to reduce HIV incidence among US gay and bisexual men: a network modeling study.BMC health services research · 2026Article
- Vaccination uptake and associated factors among HIV pre-exposure prophylaxis (PrEP) users: insights from a retrospective cross-sectional study.BMC public health · 2025Article
- Exploring Perceptions and Experiences of Health Needs Among Women Who Sell Sex.Archives of sexual behavior · 2025Article
- Preferences for Pre-Exposure Prophylaxis Implementation and Engagement in the HIV Pre-Exposure Prophylaxis Care Continuum Among Patients Receiving Psychiatric Care in an Ending the HIV Epidemic Priority County.Journal of acquired immune deficiency syndromes (1999) · 2025Article
- Pre-exposure Prophylaxis (PrEP) For Prevention of Human Immunodeficiency Virus: A Primary Practice Approach.Journal of general internal medicine · 2025Review
- Assessment of harm reduction receipt and infectious diseases outcomes in United States Veterans with opioid use disorder and history of injection drug use.Harm reduction journal · 2024Article
- HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.Journal of the International AIDS Society · 2024Article
- Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs.Open forum infectious diseases · 2023Article
- Uptake of Human Papillomavirus Vaccination by HIV Status and HIV Pre-exposure Prophylaxis (PrEP) Care Engagement Among Young Sexual Minority Men 17-24 Years Old in the USA.Sexuality research & social policy : journal of NSRC : SR & SP · 2022Article
- Pre-exposure prophylaxis as an opportunity for engagement in HIV prevention among South African adolescents.SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance · 2022Article
- Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use.JAMA network open · 2022Article
- Prescribing as affective clinical practice: Transformations in sexual health consultations through HIV pre-exposure prophylaxis.Sociology of health & illness · 2022Article
- PEP for HIV prevention: are we missing opportunities to reduce new infections?Journal of the International AIDS Society · 2022Article
- Adolescents and Young Adults: The Pediatrician's Role in HIV Testing and Pre- and Postexposure HIV Prophylaxis.Pediatrics · 2022Article
- Roll-out of HIV pre-exposure prophylaxis: a gateway to mental health promotion.BMJ global health · 2021Review
- Primary Care and Pre-exposure Prophylaxis Services in Publicly Funded Family Planning Clinics in the Southern United States.Journal of general internal medicine · 2021Article
- Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation.Current HIV/AIDS reports · 2020Review
- Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming.AIDS and behavior · 2020Article
- Pre-exposure prophylaxis and primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2020Article
- On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know.Journal of general internal medicine · 2020Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
objectivesTo determine whether HIV preexposure prophylaxis (PrEP) use is associated with use of non-HIV-related health care.
methodsWe conducted a cross-sectional study of potential PrEP candidates at a Boston, Massachusetts, community health clinic during 2012 to 2016, comparing the proportion of PrEP users and non-PrEP users receiving primary care.
resultsOf 5857 PrEP candidates, 2047 (35%) were prescribed PrEP. After adjustment for demographics and number of visits, more PrEP users received influenza vaccination (prevalence ratio [PR] = 1.28; 95% confidence interval [CI] = 1.20, 1.37), tobacco screening (PR = 1.06; 95% CI = 1.02, 1.09), and depression screening (PR = 1.07; 95% CI = 1.04, 1.11) compared with non-PrEP users. After additional adjustment for diabetes, hypertension, and overweight or obesity, more PrEP users received glucose testing (PR = 1.64; 95% CI = 1.56, 1.72) but fewer received hemoglobin A1c testing (PR = 0.81; 95% CI = 0.71, 0.93) compared with non-PrEP users.
conclusionsPrEP use was associated with receipt of influenza vaccination, tobacco and depression screening, and glucose but not hemoglobin A1c testing. Among PrEP users receiving routine care, the benefits of PrEP may extend to behavioral health, mental health, and prevention and treatment of other infectious and chronic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.